Icon Oncology

What Icon Oncology does

Icon Oncology Holdings (Pty) Ltd is South Africa's leading private cancer care services platform, operating through four core divisions: Icon Radiotherapy (26 accredited facilities equipped with 31 linear accelerators), Icon Chemotherapy (63 accredited base units plus 15 satellite units), Icon Managed Care (value-based care protocols and a medicines formulary), and Icon Network (a national specialist network representing approximately 80% of oncologists in private practice). The company delivers radiation therapy, chemotherapy, and integrated cancer management services to medical-scheme-funded patients across South Africa, supported by nearly 300 expert clinical oncology professionals and contracted relationships with most South African medical schemes.

The platform combines clinical infrastructure (a fleet of 32+ Varian linear accelerators, a wholesale pharmacy licence acquired via AG Morris International, and a R480 million property portfolio of 15 oncology partner properties) with proprietary technology including evidence-based treatment protocols shown to be 27% more cost effective than competing providers, and AI-augmented radiotherapy planning via the Limbus Contour deep-learning auto-segmentation system, which reduces contour-mapping planning time by 80-90%. Strategic technology partners include Varian (Siemens Healthineers) for linac systems, Limbus AI for radiotherapy planning software, Elekta for select installations, and Mediclinic Southern Africa for hospital-based joint ventures such as the R45 million flagship oncology unit at Mediclinic Constantiaberg in Cape Town.

Icon Oncology earns revenue primarily through contracted arrangements with medical schemes for radiotherapy, chemotherapy, and managed-care services, supplemented by hospital joint ventures, wholesale pharmacy operations, and an Icon Growth empowerment arm that enables black oncologists to acquire 51% ownership stakes. The company is privately held following a March 2024 majority stake acquisition by RMB Ventures and Bopa Moruo Private Equity alongside management. Subsidiaries include Icon Radiotherapy, Icon Chemotherapy, Icon Network, Icon Managed Care, Icon Growth, AG Morris International, and the Crayon paediatric, adolescent and young adult oncology unit launched in collaboration with Cancercare in 2023.

Name

Icon Oncology

Legal name

Icon Oncology Holdings (Pty) Ltd

Website

https://iconsa.co.za

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Icon Oncology is South Africa's leading private cancer care platform, operating 26 radiotherapy facilities, 63 chemotherapy units, and a specialist network covering 80% of private practice oncologists, delivering value-based radiation and chemotherapy services to medical-scheme patients nationwide.

Ownership category

akta.pro rank

Product category

Cancer Care Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industry

Medical Oncology (HLAKAFAB)

Keywords

• Radiation oncology services
• Chemotherapy services
• Value-based cancer care
• Oncology managed care
• Radiotherapy facilities

Headquarters

HQ city

Cape Town

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Radiotherapy and Chemotherapy Treatment Services: Icon Oncology provides radiotherapy (26 accredited facilities with 31 linacs) and chemotherapy (63 accredited base units) services. Revenue is generated through contracted arrangements with medical schemes in South Africa, with pre-approval for most treatment plans. Services delivered in both curative and palliative settings.
2. Managed Care / Value-Based Care Contracting: Icon Oncology operates as a leading value-based and care-driven organisation. Revenue derived from value-based contracts with medical schemes, reducing wastage and costs while improving outcomes. The company pioneered value-based care in South African oncology, with studies showing 27% cost effectiveness improvement over other providers.
3. Chemotherapy Supply Chain (Wholesale Pharmacy): Following acquisition of AG Morris International (Pty) LTD wholesale pharmacy licence, Icon Oncology participates in the pharma value chain including mixing facilities, administration and supply chain management for chemotherapy.
4. Property Portfolio and Facility Management: R480 million property portfolio purchase covering 15 key properties within the oncology partner network, enabling creation of one-stop oncology centres and turnkey cancer treatment facilities for practitioners.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Core offering

Icon Oncology is a private cancer care provider in South Africa delivering radiotherapy (26 accredited facilities with 31 linear accelerators), chemotherapy (63 base units plus 15 satellite units), and value-based managed care contracting with medical schemes. It combines a national network of approximately 300 clinical oncology professionals representing 80% of private-practice oncologists, with bundled-fee, pre-approved treatment plans designed to deliver evidence-based cancer care within medical scheme benefit limits.

Product overview

Icon Oncology operates as a comprehensive cancer care platform in South Africa, offering integrated oncology services through four core business divisions: Icon Radiotherapy (26 facilities with 31 linear accelerators), Icon Chemotherapy (63 chemotherapy base units plus 15 satellite units), Icon Managed Care (value-based care protocols), and Icon Network (representing 80% of private practice oncologists). The platform is complemented by specialized facilities including the Sapphire Coast Oncology Centre, Johannesburg Oncology Centre, and the Mediclinic Constantiaberg flagship unit, as well as AI-powered technology solutions like Limbus Contour for radiotherapy planning. An empowerment arm called Icon Growth enables black practitioner ownership, while the South African Journal of Oncology (SAJO) supports clinical research and education. Case management services and social grants programme extend the value-based care model beyond treatment delivery.

Differentiator

Problem solved

Functional benefit

Brands

• Crayon: Specialist Paediatric, Adolescent, and Young Adult Oncology unit
• Icon Growth

Products and services

• Icon Radiotherapy Radiation therapy services delivered through 26 accredited radiotherapy facilities equipped with 31 state-of-the-art linear accelerators across South Africa, including Varian Halcyon, TrueBeam and VitalBeam systems. Staffed by nearly 300 expert clinical oncology professionals; delivers VMAT, IMRT, IGRT and RapidArc radiotherapy and accommodates higher patient volumes.
• Icon Chemotherapy Chemotherapy treatment services delivered through 63 accredited base units (46 focused exclusively on chemotherapy and 13 providing combined chemotherapy and radiotherapy), plus 15 satellite units across South Africa. Backed by Icon Oncology's wholesale pharmacy licence (AG Morris International) covering chemotherapy mixing, administration and supply chain management.
• Icon Managed Care Value-based care organisation putting patients at the centre of care, reducing wastage and costs, and improving outcomes through evidence-based treatment protocols and a medicines formulary. Provides pre-approval for most treatment plans, case management, and bundled-fee value-based contracts with medical schemes; documented as 27% more cost effective than other providers.
• Icon Network Integrated network of oncologists, radiotherapists, chemotherapy nurses and social workers representing approximately 80% of private-practice oncologists in South Africa. Provides affiliated oncologists with contracted patient base access, clinical IP, treatment protocols, and managed care infrastructure.
• Crayon Paediatric, Adolescent and Young Adult Oncology Unit Specialist Paediatric, Adolescent, and Young Adult Oncology service delivering multidisciplinary cancer care tailored to young patients. Established as a collaboration between Icon Oncology and Cancercare to provide dedicated oncology services for children, adolescents and young adults in the Western Cape and beyond.

Quantifiable outcome

• 27% more cost effective than other providers whilst delivering improved patient outcomes
• +4 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered major, minor and core.

• ABJ OncologymajorStrategic or Co-development Partner · 27 February 2026ABJ Oncology is a respected oncology practice and valued strategic partner of Icon Oncology. Together they deliver multidisciplinary, patient-centered cancer care grounded in clinical excellence, collaboration and compassion. Hedri Powell, an ABJ Oncology social worker and counsellor, is featured as a patient case study demonstrating the quality of the Icon network's care.
• Tymeless Necessity HairminorGTM or Marketing Partner · 25 February 2026Small female-led BBBEE company in Johannesburg that received a 2022 Icon Oncology grant to train wig manufacturers, providing practical tools to create high-quality wigs for cancer patients. Collaborates with the Cancer Association of South Africa (CANSA).
• The Breast Health FoundationminorGTM or Marketing Partner · 25 February 2026Breast cancer advocacy and awareness organisation that received funding through Icon Oncology's Social & Economic Development Grants Programme. Supported in 2025 alongside other community-based projects addressing patient dignity, wellness and breast cancer awareness.
• Reach for RecoveryminorGTM or Marketing Partner · 25 February 2026Breast cancer support group that received grant funding through Icon Oncology's SED Grants Programme. Icon Oncology also helped pay rent for the Ditto Project's new offices in Cape Town, which provides free breast prostheses to state patients who have undergone mastectomies.
• Look Good Feel Better South AfricaminorGTM or Marketing Partner · 22 August 2023Icon Oncology awarded a R100,000 socioeconomic development grant to Look Good Feel Better South Africa, a national NGO hosting self-care workshops for people living with cancer. The partnership benefits uninsured cancer patients from state hospitals, helping them manage appearance-related side effects of chemotherapy and radiotherapy.
• CancercaremajorStrategic or Co-development Partner · 16 June 2023Strategic collaboration to establish a dedicated cancer treatment unit for young people (Crayon Paediatric, Adolescent and Young Adult Oncology unit) in the Western Cape and beyond. Specialist team unites to fight cancer in young people, addressing the unique needs of paediatric and adolescent cancer patients.
• Limbus AIcoreTechnology or Integration · 25 January 2022Partnership to pioneer radiation AI software in Southern Africa. Limbus Contour AI software deployed across Icon Oncology's radiation oncology facilities. Uses deep-learning auto-segmentation to speed up contour-mapping process by 80-90% with accuracy equal to manual mapping. The software automatically delineates organs at risk during radiotherapy planning.
• Varian (Siemens Healthineers)coreTechnology or Integration · 14 December 2021Strategic partnership establishing a value-based cancer treatment hub for Southern Africa. Includes investment in seven new linear accelerators (Halcyon and TrueBeam radiotherapy systems) and associated software solutions. Varian provides skills development, local training of Icon Oncology professional staff, and maintenance support. Expands Icon Oncology's fleet to 32+ Varian linear accelerators.
• Mediclinic Southern AfricacoreStrategic or Co-development Partner · 25 August 2021First-in-South Africa partnership delivering seamless one-stop oncology services at Mediclinic facilities. Joint venture at Mediclinic Constantiaberg (R45 million investment) brings together radiotherapy and full-service chemotherapy under one roof. A multi-disciplinary team of oncologists operates within the hospital. Partnership aims to expand one-stop centres across South Africa.
• South African Journal of Oncology (SAJO)minorStrategic or Co-development Partner · 9 April 2021Icon Oncology's Head of Clinical Governance serves as Chief Editor of SAJO, an open-access oncology journal that received DHET accreditation in 2021. The journal publishes high quality articles on all aspects of oncology supporting a multi-disciplinary approach to cancer care and research.

Scale indicators10 records

Recent moves10 records

Expansion highlights7 records

Direct peers

• Cancercare: South African oncology practice group and Icon's stated strategic partner. Provides radiotherapy and chemotherapy services nationwide and directly competes for the same private oncology patient pool, with overlapping physician relationships.
• Mediclinic Southern Africa: Hospital group and Icon's JV partner at the Constantiaberg oncology unit. Operates its own oncology services and is both a collaborator and a potential competitor depending on JV structure and geography.
• GenesisCare: Global oncology network operating radiotherapy and chemotherapy centres across Australia, Europe, and the US. Closest international comparable in business model: scaled multi-site oncology with value-based contracting orientation.

Broad incumbents

• Life Healthcare: Largest private hospital group in South Africa offering oncology services within its acute-care network. Comparable as a private acute-care provider competing for the same medical scheme oncology spend, though oncology is one of many service lines.
• Netcare: Major South African private hospital and oncology provider with radiotherapy and chemotherapy units. Competes with Icon for scheme-funded oncology volume while running a broader hospital portfolio.

Emerging players

• Icon Group (Australia): Australian-headquartered provider of radiation oncology, pharmacy and compounding services. Comparable as a vertically integrated oncology platform with global expansion ambitions, though focus has been Asia-Pacific rather than Africa.

Others

• Elekta: Global vendor of linear accelerators and radiation oncology software. Comparable as the alternative technology stack to Varian that Icon now also uses (Sandton Elekta installation), shaping competitive technology choices in the segment.
• Varian Medical Systems (Siemens Healthineers): Core technology partner supplying Icon's Halcyon, TrueBeam, and VitalBeam linac fleet. While not a treatment competitor, Varian's product roadmap and pricing directly drive Icon's cost structure and differentiation.
• Medscheme: South African medical scheme administrator and former employer of Icon's CEO. Functions as a payer-side counterparty that helps shape oncology benefit design and reimbursement models influencing Icon's revenue.
• National Department of Health (South Africa): Regulator and public oncology buyer whose NHI and PPP policies materially affect Icon's addressable market. Relevant as the architect of the public-private oncology framework Icon is positioning to participate in.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/IconOncologySA
• YouTubeyoutube.com/channel/UCGXQeAwDCtFZeC-A8BMt4Ng?view_as=subscriber
• Facebookfacebook.com/iconsouthafrica
• LinkedInlinkedin.com/company/iconsouthafrica

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Icon Oncology